Last edition
News about Drug Discovery & Development
Scenic Biotech Enters into Research Partnership with Bristol Myers Squibb
Scenic Biotech has entered into a research collaboration with Bristol Myers Squibb to accelerate the development of Bristol Myers Squibb’s drug targets by identifying target biology for indication selection and expansion.
Drug Discovery & Development | 01/05/2024 | By Aishwarya | 455
Lupin Launches Mirabegron Extended-Release Tablets in US
Lupin Ltd. has developed Mirabegron Extended-Release Tablets, 25 mg, in the United States, after having received approval from the United States Food and Drug Administration (US FDA).
Drug Discovery & Development | 22/04/2024 | By Aishwarya | 613
SII Joins Hands with Univercells to Make Personalized Oncology Affordable
The new therapies are developed using genetic material extracted from the patient’s tumors, a process which is both time-consuming, and expensive.
Drug Discovery & Development | 12/04/2024 | By Manvi | 665
Syntekabio to Showcase its AI Drug Discovery Tech at Bio-IT World Expo
Syntekabio, a global artificial intelligence (AI) drug discovery pioneer, has announced its participation at the upcoming Bio-IT World Conference & Expo.
Drug Discovery & Development | 12/04/2024 | By Aishwarya | 587
TPM-1116 represents a new chemical series of OX2R agonists with the potential for a best-in-class clinical profile.
Drug Discovery & Development | 11/04/2024 | By Manvi | 821
Sartorius and TheWell Bioscience to Enable More Accurate Predictions in Drug Discovery
Sartorius has teamed up with TheWell Bioscience on the further development of hydrogels and bioinks tailored to produce 3D advanced cell models for drug discovery workflows.
Drug Discovery & Development | 10/04/2024 | By Aishwarya | 349
Lupin Rolls Out First Generic Version of Oracea
Lupin has unveiled the first generic version of Oracea (Doxycycline Capsules, 40 mg), in the United States.
Drug Discovery & Development | 10/04/2024 | By Aishwarya | 661
AustinPx Invests in Pharmaceutics and Manufacturing Capabilities to Boost Drug Development
The latest investments enhance AustinPx’s early phase development and manufacturing capabilities by enabling faster timelines, improved stability, and reduced risk.
Drug Discovery & Development | 09/04/2024 | By Manvi | 645
Dr Reddy's, Bayer to Market Second Brand of Vericiguat in India
Dr Reddy’s Laboratories has joined forces with Bayer to introduce a second brand of Vericiguat, a medication for chronic heart failure, to the Indian market.
Drug Discovery & Development | 08/04/2024 | By Aishwarya | 1563
Acumen Pharmaceuticals Join Hands with Lonza to Bolster Sabirnetug Production
Acumen Pharmaceuticals has signed a partnership agreement with Lonza, a global partner to the pharmaceutical, biotech, and nutraceutical markets.
Drug Discovery & Development | 05/04/2024 | By Aishwarya | 780
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy